Medicamen Biotech Ltd Q1 FY2026-2027 Results: Summary
Revenue | ₹48.76Cr |
Net Profits | ₹2.12Cr |
Net Profit Margins | 4.35% |
Medicamen Biotech Ltd’s revenue jumped 12.04% since last year same period to ₹48.76Cr in the Q1 2026-2027. On a quarterly growth basis, Medicamen Biotech Ltd has generated -21.83% fall in its revenue since last 3-months.
Medicamen Biotech Ltd’s net profit fell -1.4% since last year same period to ₹2.12Cr in the Q1 2026-2027. On a quarterly growth basis, Medicamen Biotech Ltd has generated -45.08% fall in its net profits since last 3-months.
Medicamen Biotech Ltd’s net profit margin fell -11.99% since last year same period to 4.35% in the Q1 2026-2027. On a quarterly growth basis, Medicamen Biotech Ltd has generated -29.74% fall in its net profit margins since last 3-months.
FAQs
What was the revenue for Medicamen Biotech Ltd in Q1 results 2026?
The revenue for Medicamen Biotech Ltd in the Q1 results 2026 was ₹48.76Cr.
What was the net profit for Medicamen Biotech Ltd in Q1 results 2026?
The net profit for Medicamen Biotech Ltd in the Q1 results 2026 was ₹2.12Cr.
What was the net profit margin for Medicamen Biotech Ltd in Q1 results 2026?
The net profit margin for Medicamen Biotech Ltd in the Q1 results 2026 was 4.35%.
What was the revenue for Medicamen Biotech Ltd in Q1 results 2025?
The revenue for Medicamen Biotech Ltd in the Q1 results 2025 was ₹43.52Cr.
What was the net profit for Medicamen Biotech Ltd in Q1 results 2025?
The net profit for Medicamen Biotech Ltd in the Q1 results 2025 was ₹2.15Cr.
What was the net profit margin for Medicamen Biotech Ltd in Q1 results 2025?
The net profit margin for Medicamen Biotech Ltd in the Q1 results 2025 was 4.94%.
